Grant: Research Tools and Instruments
McGill University
$148,621.00
Droplet Digital PCR for absolute quantitation of viral-based biologics
FY 2016-17
Summary
A droplet digital PCR (ddPCR) system is requested to reliably and reproducibly quantify the absolute concentrations of viral products in cell culture productions of viral vaccines and viral vectors for gene delivery. The ddPRC system will also be used to characterize rare cell population in stem cell cultures. The acquisition of ddPCR, such as the Biorad QX200 with AutoDG AutoDroplet Digital PCR System in the bioprocessing of viral vectors and vaccines laboratory, Bioengineering Department at McGill University represents a significant time and cost saving on operations. ddPCR allows detection of virus at lower levels than is presently possible, minimal consumption of precious samples and better comparison of results. Much of the ddPCR is automated and reference standards are not required, improving the statistical reliability of research conclusions within shorter timelines and at lower costs of operation since no reference standard material is needed. The equipment is critical for the research programs of the applicant to deliver more rapidly and more effectively on NSERC-funded CRC-1 and Discovery programs as well as NSERC-funded strategic projects, pivoting on the bioprocess science and technology of viral vectors and viral vaccines. The equipment will also be actively used by members of the Stem Cell Bioprocessing Laboratory in the Department of Chemical Engineering in order to quantify gene expression by rare stem cell and stem cell-derived populations for higher quality results delivery and acceleration of discovery on stem cell-based projects of the co-applicant. Overall, the implementation of ddPCR as an advanced process analytical technology will accelerate the vaccine and applied virology research and development and will result in new findings and accelerated translation of research results with industrial partners and increased impact. The applicant's colleagues from the newly created bioengineering department share the needs for such equipment to reliably quantify nucleic acid elements involved in their research activities. The high frequency use of the equipment for determination of viral genome titers will expand with the number of products derived from virus, cell culture and stem cells that are studied in the current and future NSERC-funded projects and other projects with institutional partners engaging more users and importantly training more graduate students on this core analytical technology.
Program
Research Tools and Instruments
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RTI-2017-00323
Name nom
Kamen, Amine
Department département
Bioengineering - Bioengineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2017
Award amount
148621
Program id
RTI
Program name en
Research Tools and Instruments
Program name fr
Outils et instruments de recherche
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1609
Committee name en
Engineering (RTI)
Committee name fr
Génie (OIR)
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Droplet Digital PCR for absolute quantitation of viral-based biologics
Keyword
NSERC
Application summary
A droplet digital PCR (ddPCR) system is requested to reliably and reproducibly quantify the absolute concentrations of viral products in cell culture productions of viral vaccines and viral vectors for gene delivery. The ddPRC system will also be used to characterize rare cell population in stem cell cultures. The acquisition of ddPCR, such as the Biorad QX200 with AutoDG AutoDroplet Digital PCR System in the bioprocessing of viral vectors and vaccines laboratory, Bioengineering Department at McGill University represents a significant time and cost saving on operations. ddPCR allows detection of virus at lower levels than is presently possible, minimal consumption of precious samples and better comparison of results. Much of the ddPCR is automated and reference standards are not required, improving the statistical reliability of research conclusions within shorter timelines and at lower costs of operation since no reference standard material is needed. The equipment is critical for the research programs of the applicant to deliver more rapidly and more effectively on NSERC-funded CRC-1 and Discovery programs as well as NSERC-funded strategic projects, pivoting on the bioprocess science and technology of viral vectors and viral vaccines. The equipment will also be actively used by members of the Stem Cell Bioprocessing Laboratory in the Department of Chemical Engineering in order to quantify gene expression by rare stem cell and stem cell-derived populations for higher quality results delivery and acceleration of discovery on stem cell-based projects of the co-applicant. Overall, the implementation of ddPCR as an advanced process analytical technology will accelerate the vaccine and applied virology research and development and will result in new findings and accelerated translation of research results with industrial partners and increased impact. The applicant's colleagues from the newly created bioengineering department share the needs for such equipment to reliably quantify nucleic acid elements involved in their research activities. The high frequency use of the equipment for determination of viral genome titers will expand with the number of products derived from virus, cell culture and stem cells that are studied in the current and future NSERC-funded projects and other projects with institutional partners engaging more users and importantly training more graduate students on this core analytical technology.